Quaker Chemical Q4 sales up 6% to $468.5 million; full-year net loss $2.5 million
Quaker Chemical reported fourth-quarter 2025 net sales of $468.5 million, up 6%, and net income of $20.7 million, or $1.18 per diluted share, versus $0.81 a year earlier. For the full year, the company posted a net loss of $2.5 million, or $0.14 per share, compared with net income of $116.6 million in 2024, after an $88.8 million impairment charge and $35.1 million of restructuring charges. Management expects end markets to remain at similar levels through the first half of 2026 and says it is confident in revenue and adjusted EBITDA growth in 2026, but the filing gives no numeric guidance.
Key points
- Q4 2025 net sales were $468.5 million, up from $444.1 million; net income was $20.7 million, or $1.18 per diluted share, versus $0.81 a year earlier.
- Full-year 2025 net loss of $2.5 million ($0.14 per diluted share) compared with net income of $116.6 million in 2024, including an $88.8 million impairment charge.
- Q4 adjusted EBITDA rose 11% to $71.9 million; full-year non-GAAP EPS was $7.02 versus $7.44.
- Operating cash flow was $136.5 million in 2025 versus $204.6 million in 2024; net debt was $691.4 million at December 31, 2025.
The filing
Written by AI on Nov 8, 2026, 1:49 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 23, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.